Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Your tumor type was not appropriate for the trial. Your desire to ruin access for other patients is bizarre and immature. I can’t imagine it would be considered in any context as reflective of anything about the company or DCVax-L.
5 months of direct testimony. You must’ve been in their offices every day.
He’s making bizarre claims and trying to undermine the treatment that was not appropriate for his form of brain tumor, for other patients. A kind of bitter response that it is impossible in any context see as a mature or positive kind of behavior.
You subsequently clarified you did not have GBM, and were diagnosed with Astrocynoma Wild Type brain tumor.
What grade was the tumor?
You definitely would not likely be considered at all for a Glioblastoma trial, though I would guess it would be a disappointment. Doctors screening you were not “the Company”. That would be that hospital and doctor, following the basic requirements of the trial.
It actually speaks well of the trial that you were not included in that trial, rather than the opposite, even if you’d perhaps have wished otherwise. Further, your resentment is proof of their care despite the fact that you resent them for it and made a point of trying to undermine the treatment and company for other patients… assuming your story is true.
It doesn’t affect the chief compliance guys. In fact, they fail upward. Unfortunately.
But he will get to fire all the “bad apples” with a totally serious face, before he gets fired and fails upward into a bigger and better job.
He’ll tell the board, they will have to investigate the primary person, and if they are smart, given his social media activity, they will fire him… to preserve the organization, and everyone will go down together…. Except a few of them will definitely fail upward… there are always key people who fail upward.
Let me put it more clearly for you. If I tell my programmer to create an algorithmic system that “gets the best price” for my customers, and he does the math and inadvertently realizes that trading activity that a judge would dub intentional spoofing, is the best way, but the programmer doesn’t know it’s illegal, and the buyer of the software “ claims he know” it was spoofing, but that is, in fact, what it did, the intent IS there, regardless of what everyone claims they knew, claims they did not know, wished they knew, etc. the intent is not what you think it is, and plausible deniability is not going to likely suffice.
Not if it is algorithmically created, you don’t understand the nature of institutions, or the concept of intent. Intent to do the act, or facilitate customer trading using a tool that someone put into commerce without properly determining if it violated the law or not. Intent is “diffuse” in this context, and not what you think it is….
You don’t have to have what some people think, in order to get to the relevant “intent”… and the problem with a matured on bulletin boards or at investment managers is that they think they can hide behind tools, tools they may very well know are not kosher but that they can plausibly deny they knew were spoofing. But spoofing is a clear cut activity. All you need to prove is that there was actual spoofing, it doesn’t require the level of knowledge you think. It is just that the right cases have not yet been litigated. I suspect this is going to be the right case.
The reality is that people writing these things think that our laws clearly give them some sort of all clear sign to break the law, but we have a case law system where new technologies and ideas reveal themselves only gradually, and as the system becomes more aware of the nature of systems, they will apply the relevant rules. But the people who are doing these things, they think last year’s very poor case dictates how a court will perceive their activity. That is not true at all.
Agreed. If shorts do not think there won’t be screams for blood in the streets and their actual scalps, they have not been paying attention. This is broad based. There will be demands for criminal prosecution. There will be demands for more restrictive regulation of short trading and especially by hedge funds in small markets where they have outsized impact and can control a market price and undermine fair market mechanisms.
I have no doubt about it because I know people who will likely be working on that with all the usual characters in Congress to get those bills through. And if they do not believe that with the various states now smashing the gerrymandering in states like WI, Dems won’t take control of both houses, with abortion rights on the ticket in this election, then they are seriously out to lunch.
Better settle this thing quickly, because all of the tea is going to be spilt. There will be nowhere to hide. No anonymity. For short traders, I guarantee that will come to an end, and it will be because of market manipulation and licenses, so free speech will no longer be relevant, you just won’t have licenses to trade anymore. Post all you want, as a professional barred from the securities markets and only able to trade personally, as just another retail schlub. Sure, you’ll have more dollars, but less access and you’ll be completely visible to every regulator.
Whatever you may be thinking, pride, ego, or just plain stupidity, this stock and company could easily be the end of your future in finance, for the rest of your life. May sound over the top, but it happens. Wouldn’t want to be a stock manipulator for a job. Or any one of you can turn in whomever you’re working for, for 10-20% of whatever the government recovers from the illegal activities going on manipulating these stocks. Once they reveal it and put it on the table, that information is worthless. Go forward now, anonymously to the regulators, you can get a cut, to set yourself up for life. Let them pull down every trade every person who is coordination with anyone else, any broker-dealer that allows their customers to do the dirty deeds for extra returns… to look good to their institutional investors. The embarrassment for those institutional investors, would ruin any investment advisors business, and certainly they would need to do an extremely conspicuous house cleaning.
I think this is your issue. Thugs get no sympathy. Go to jail, skip next turn.
Agreed. Intent is not relevant, at this time. And the focus is not on an intention of the broker dealer to break the law, lie or do anything specifically “wrong”, just that they did things that were, in fact, wrong, I.e. that constituted spoofing or that involved an algorithm that spoofed and the person using the algorithm did not need to know the algorithm, in fact, spoofed a share price. People who think they need to have “intended” to do wrong, are sorely mistaken. These are organizations, and the blame is often diffuse when they engage in actual illegal acts.
Not true, and it is very common for shorts to trash a stock when a company is awaiting approval and even after approval.
You should not be in this asset if you don’t know the space, but given your history, I doubt the primary interest you hope to gain from is a long position. Some people are swing traders and they own some long shares, but they seek to increase swings with non-stop negativity when they are trying to swing the price back down. So they can present themselves as “longs”, because they hang out for a long time and they often own some shares on a long basis, but at any given moment their primary interest can be the opposite of a long.
There are also many traders who are mostly short, but hold shares so that they can claim to actually be “shareholder activists”. This allows them to legally behave extremely badly, but always under the legal guise of “shareholder activist”, making prosecution difficult.
These guys know if they do not bankrupt this company, not just their balance sheets blow up, but their reputations. They have so much to lose for dogging such an important company and treatment relentlessly for years. They will be viewed as gangster like thugs who took the absolutely most unethical and extreme means to make money in the history of Wall Street. It will be such an immense embarrassment and scandal like we have not seen in some time. It’s not financial at root, huge because it’s a small group of us investors who are being scammed by shorts, but it is a profound revelation on the nature of short traders who are so deeply soulless, so without ethics or standards of behavior that they would engage in deeply unethical behavior just for really not very much money, just for their egos.
People will literally hate these people. I would not be surprised if cancer patients wait to throw fake blood on them whenever they go. Seriously soulless individuals who deserve no place of honor in our society at any level. Lower than the lowest fungal or bacterial or viral life forms.
And everyone will be after their scalps in the financial markets. They should plead for a settlement. Their reputations are already in tatters, they should save what they can.
Total crap. They are thinly staffed and clearly in the midst of a complex approval for a first of its kind product that is a vaccine customized to every individual patient’s actual tumor using their own immune cells.
There is nothing like it in the world. Never has been. It has been immensely successful and they have other processes that also require regular attention. But there has never, ever been any such indication just fake allegations by fake posters who will never disclose their interests.
Intent to do the act that led to the bad thing is not necessarily difficult to prove. Usually, it is quite obvious. If they spoofed, you don’t have to prove they intended to do it. They did it or they did not, if they did it, the intent to do those specific things that spoofed the stock is more than adequate. If they created software that did prohibited things, likewise. Not so good for them. Don’t have to prove that the employee that then used the software, who did not know it spoofed stocks, thought he was doing something wrong.
Not unlike many torts, often people do things that are wrong, not with the intention to do “wrong”, but just the intent to do the act that caused a wrong.
Summary from another site. I note that the FT tweeted that article out as well.
“A group of Wall Street traders maliciously drove down the share price of a Maryland biotech with a promising new brain cancer vaccine, in pursuit of the marginal profits to be made by buying the stock cheaply and selling it back to the market.
In other words, if Citadel Securities and its ilk are to beat this case and prevent a string of copycat suits, they will probably have to give the rest of us more of a peek behind the curtain.
In a line that seemed destined to make its way on to the r/wallstreetbets message boards on Reddit, Stein further called the claims “cogent and at least as compelling as the inference that defendants were simply engaged in legitimate trading activity.”
https://beamstart.com/news/spoofing-case-might-draw-back-17093564962934
I did have a subscription to FT. But it’s not needed at the current time.
And here is another summary:
“EQUITIES
Allegations of Market Manipulation Against NWBO Spark Legal Battle
NWBO's 'spoofing' lawsuit against top broker-dealers dismissed but court sees potential for case to reveal high-speed trading practices.
?
13 hours ago
Key Takeaway
Northwest Biotherapeutics accuses Virtu and Citadel Securities of "spoofing" to lower NWBO stock, despite positive trials.
Manhattan court dismisses case against Citadel due to lack of evidence but acknowledges the plausibility of NWBO's claims.
NWBO's planned refiling could expose high-frequency trading practices, signaling a shift in handling market manipulation allegations.
Allegations of Market Manipulation
Northwest Biotherapeutics has accused seven broker-dealers, including Virtu and Citadel Securities, of engaging in "repeated spoofing" to drive down the share price of NWBO. The company alleged that these firms placed millions of sell orders they had no intention of fulfilling, leading to a significant drop in NWBO's valuation despite positive clinical trial results. The lawsuit sparked interest among Redditors, who speculated about hedge funds' motives and governance issues within NWBO.
Read more in other views:
POSITIVE
Innovative NWBO's Brain Cancer Vaccine Draws Investor Support Amid Legal Drama
NEGATIVE
Market Manipulation Allegations Cast Shadow Over Northwest Biotherapeutics' Share Price
Legal Developments
A Manhattan court recently dismissed NWBO's case against Citadel and others, citing a lack of evidence tying the alleged trading to specific losses. However, the court acknowledged the plausibility of most of NWBO's claims, suggesting that the case could proceed further. Magistrate Gary Stein found the distinction between cancelled and reduced orders unconvincing and noted the potential impact of defendants' conduct on NWBO's stock price.
Market Impact and Future Actions
NWBO plans to refile its complaint, potentially leading to the discovery process where internal records and communications from the defendants could be revealed. The outcome of this case could shed light on the practices of high-frequency trading firms and their influence on global markets. While Citadel Securities dismissed the lawsuit as malicious, the court's decision signals a shift in the default stance of market-makers regarding allegations of market manipulation.”
https://wallstreetnow.co/en/articles/2024/03/02/allegations-of-market-manipulation-against-nwbo-spark-legal-battle
Making waves…
‘Spoofing’ case might draw back curtain on high-speed trading firms https://t.co/vjHn2BPLeM | opinion
— Financial Times (@FT) March 2, 2024
You are correct.
Calendar days. Not business days. They would say Business days. Business daddy is a well understood but qualified and defined term and clarification. But you define it so that people coming to a document know you do not mean “calendar days”. This is a public website of a government agency. It is calendar days unless they say conspicuously, and define it as Business Days.
Our little friend has no idea of what she speaks and knows just enough to be a vandal.
It would not make serial processing impossible. And nothing I said suggested any specifically necessary or unnecessary context. Any such condition, if it existed, and it certainly could, would prevent serial processing. That’s a very flat world way of thinking about such things.
The whole point of and meaning ultimately of “automation” is serial processing and increasing efficiency. All kinds of processes that are complex and for which early simple minds had no conception of serial processing have been automated in such fashion and this will likely be as well. But at the moment, it is likely too complex and not necessary to get the initial scale that they need. However, I doubt very much the limitations people calculate here based on publicly available information and speculation is, in fact, a true upward limit. The whole point of putting processes inside of small, contained packages is, ultimately, serial processing. Initially it is simplest by machine. Ultimately, that won’t likely last as the upward limit because that is not real manufacturing technology, at its upward limit and the process innovation by itself suggests that they know that as well.
I expect someone told the first inventor of vacuum tubes that they might be able to fit more of them together somehow, the person might have said, that's impossible. Or after the first transistors were built, someone said, putting multiple transistors into a smaller space would be impossible, because x, y and z. But anyone with any sense of technology today knows where those inventions inevitably led. Today there is an obviousness about technologies and putting a process like this into a "cartridge" screams serial processing. Right now it is PER MACHINE. Whether the people move, or the cartridges move, ultimately, or the cartridges move sideways or up and down, it makes no difference. The invention obviates serial processing because that is where efficiency will be gained and that is how technologies like this evolve. End of story.
I believe they will be able to do serial processing in these units. The whole point of them is that they are doing the work inside of a sealed cartridge, hence the elimination of cleanrooms. When the product is idle, and the cells are digesting, discovering and processing antigens, there is no reason why the next cartridge cannot be in process, in the long-run. I think per unit they will ultimately do far more than 50 a year. It’s clearly what the technology was ultimately invented to achieve.
I think ultimately, the company will need to consider scaling that process beyond individual units as well, to automate beyond and to where the cost can be scaled waaaay down.
This is an encouraging article!
That page appears to 1) only list research that NBTS has funded and 2) Be primarily about their collaboration with Parker Institute for Cancer Immunotherapy, which is affiliated with Sloans Kettering… so of course they are going to talk about their own research, even if it has not been effective so far.
The date is irrelevant. That post was more relevant than 90% or more of the moats on the board on a daily basis. The truth is that those are the results of the trial, relevant to this vaccine and this company, being trumpeted by one of the top research center schools in the nation. UCLA and other schools have said similar things about the trial and DCVax-L, plus it is stated right there, it is not just a “breakthrough” for Brain Cancer, it is “non-toxic”!
It is more relevant than anything you have probably ever posted on this website or anywhere else about DCVax-L or NWBO.
It’s a contingent fee lawsuit… the lawyers they pay for are those getting them through the drug regulatory process, IP lawyers and any regular and normal costs for securities compliance and corporate necessities and compliance.
No, they will fill the board. Plus it honestly long arguments and inprobes the ability to rebut every argument. This is a waste of time as well though.
Have you fed the yahoo board or ever posted over there? 1) as long as anyone read it it was saturated with all basher posts. 2) if you posted anything positive, your post became the focus of basher posts. In the context where we dominate, they are also kept in check.
Otherwise, I do not see you posting a lot that would change the narrative. You seem to be making their case for them. Just a different angle. Like I said, some longs are swing traders.
First of all, you reply to a one sentence post implying I said all kinds of speculation, but that’s not there.
Second, the CDMO they needed did not exist. CRL saw it as unique as well and paid 1 billion for it and she was not the sole owner. The shorts were responsible for blowing that company up however. The result was that the company that had done all of their manufacturing during the clinical trial, and would enable easy approval, therefore, had its UK subsidiary and the CEO was in a position to save it and have it spun out for NWBO’s benefit.
So yeah, we were fortunate not to be required to hire CRL at great expense at this point and likely not in NWBO’s own factory, to develop commercialization plans.
You make it sound like a huge disadvantage, but the reality is entirely the opposite. But if she did not own it and it was the other scenario, and they were diluting now madly to raise funds for CRL, you’d be saying something much more negative. The reality is, nothing they do would ever be praised by you and your crowd. Your job is just to find anything you can EXPLOIT ti make your false light case.
Downrating doesn’t make the posts disappear. That would work in a social media site where ratings impact views. This is not that forum. It works on Twitter. Not here. Bulletin boards are a different animal. If you surrender bulletin boards, as with yahoo, and do not rebut the misinformation, the misinformation becomes the current view. They become useless wastelands.
Real rebutting, not name calling or just yelling at them, undermine’s their narratives and actually frequently makes them realize their latest attack isn’t working.
On Twitter, you ignore and block accounts with zero to two followers so that they do not attach to your own posts and free ride to your followers.
People need to understand how social media and different forums work.
Longs are Tricksy Hobbits huh?
Seriously, though, you sound like Gollum half the time.
What provable fact have you focused on today or in the last week?
Quit pretending Mr year after year as a short, that you’re concerned about investors… crock…
It’s so obvious.
Nonsense. The moment is the moment. It has nothing to do with Sojo. Shorts are working those 24-7 right now uhum.
Thanks Stonk. Something real with regard to the MAA application, rather than the basher crap.
Ignore does not prevent the board from being filled. This is not Twitter where responding creates “followers”… they just post until they fill the board. The people who never post complaining about people rebutting the bashers is rich.
Give it a break. Your fake nonsense based on your desire to miscast things is total garbage. You have absolutely no basis to make these claims. You just think if you post it you can convince “idiot retail”…. This is the crap that hedge funds pay well four guess, especially when a company goes much further and than they expected and they need to squeeze that price before approval. Total BS, with your “straight man”… to make it sound legit.
The submission was PR’d. The eMASS system MHRA uses gives them an immediate acknowledgment, which is what the PR was based on. They only get anything subsequently about acceptance if there were problems.
There is not a second, “We acknowledged it previously but we just want you to know we still have it.” Acknowledgment. The eMASS system was supposed to provide that unless there is something wrong.
This I have confirmed repeatedly with various sources.
I agree Doc. The board would be come Yahoo, which is actually what they want. This board has kept people interested and maintained unity between longs in terms of sharing ideas and information, and not particularly pumping. Even for me there are people who say things I find unrealistic, but I in no way think they were paid or are pumping. People have different ways of processing information and different levels of understanding as well as different levels of optimism and different expectations. But it is obvious that there is a difference between those whose motivations are clear and disclose their position and holdings and those who keep it all a secret but reveal their motivations by their nonstop bashing.
They have to go back almost 20 years, to mistakes by PREVIOUS management... who clearly were just in over their heads...
There is no need for the specials program once DCVax-L is approved and in fact you’d not sell a licensed drug under that program.
I think as to already incurred expenses and paying down their account, this is also my opinion. And income recognition may not be immediate as well because of complexities with those incurred costs and also the specials program and the ways in which payment may be received. But I do not claim to know anything.
As a follow-up to that post, and anyone reading this should read the post to which I’ve responded. Dr. Malik was appointed to the Board of NWBO in 2012.
In 2011, he was rated quite highly…
Advent was a spin out from Cognate which manufactured DCVax-L during the trials and for that reason enabled consistency and the continuation of knowledge already acquired over years. It was brilliant for that to occur. As you likely know but will no doubt deny, shorts manufactured false light based financial havoc for both NWBO and Cognate when they blew up supplier based financing using the shares of NWBO as payment over years. Cognate ended having to sell itself off to CRL: https://ir.criver.com/news-releases/news-release-details/charles-river-laboratories-acquire-cognate-bioservices-create
Being able to retain that knowledge and information developed through Cognate for NWBO, and enable continuity for not the Specials Program and for full commercial licensing was brilliant and foiled shorts in a million unknown and untold ways.
What really pisses shorts off is that even when they blew things up, it created new opportunities to create a new structure for manufacturing, which I explained in my recent previous posts, that angers them to no end… it’s scalable, and NWBO will add automation shortly, apparently, and if you’re a short, that is so disappointing… so, we are playing the “Hey, look over there!” game again. That’s what all the focus on random old news is all about… Hey, don’t pay attention to the application with MHRA or that new PR about Flaskworks, look at this almost 20 year old PR, etc. wasting all of our time…
As for the so called “pumper” on the board, which is total garbage, you mean this gentleman:
https://thelifesciencesdivision.com/about/our-team/
Yeah, the clip used to be ready available all over YouTube but it popped up prominently when Cramer was getting a lot of negative attention and they had a service apparently go and remove all of them.
You presume just because you know the general details of a contract you can understand everything.
The general terms of their contracts are outlined in their financials. It doesn’t mean you’ll understand or know everything about them.
We have yet to receive their annual report for 2023, but we do know the company has funded development. We also know they cannot market. We do not know how much substantial revenue or when if any, it has come in on the specials program.
We do know that Sawston is the means and Advent is the service provider in the UK. This makes sense since NWBO itself doesn’t do manufacturing, it contracts that service out.
The space leased is not the same it’s the services provided nor the infrastructure built for Advent to provide the services. Advent is under contract. Advent is required to provide the services to NWBO when there is demand, and the requirement under the regional development contract to help other companies would be a cost to NWBO, not revenue. But it does help subsidize the building, staffing and maintaining if a GMP facility to manufacture DCVax-L at reasonably low cost to NWBO and it is a small portion of the ultimately available space.
Effectively, it isolates what would be a serious COST center off of the balance sheet with set costs that are more manageable and that can be symbiotically subsidized, for now, and that facility s the germ seed for the larger facility that will likely use different technology and be automated. It is a perfect launch pad and allows manufacturing to be scaled as needed, which for this are, in biotech, is extremely innovative.